Aerovate Therapeutics Inc Financial Flexibility Index
Aerovate Therapeutics Inc financial flexibility index. Aerovate Therapeutics Inc (AVTE) has a Financial Flexibility Index of -0.96x as of March 2025. Free cash flow of $-2.38 Million (operating CF $-2.38 Million minus capex $0.00) represents -1% of total liabilities ($2.49 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Aerovate Therapeutics Inc (2019–2024)
Financial flexibility index of Aerovate Therapeutics Inc from 2019 to 2024. Historical Financial Flexibility Index trend for Aerovate Therapeutics Inc across 6 annual periods. Explore how well can Aerovate Therapeutics Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Aerovate Therapeutics Inc Financial Flexibility Index by Year (2019–2024)
Aerovate Therapeutics Inc financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for Aerovate Therapeutics Inc. For the full cash flow conversion analysis, see AVTE operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -18.26x | $-71.20 Million | $-71.20 Million | $3.90 Million | ▼ -479.3% |
| 2023 | -3.15x | $-56.64 Million | $-56.78 Million | $17.96 Million | ▲ +30.7% |
| 2022 | -4.55x | $-38.93 Million | $-39.12 Million | $8.56 Million | ▲ +50.8% |
| 2021 | -9.24x | $-27.22 Million | $-27.40 Million | $2.94 Million | ▼ -2073.8% |
| 2020 | -0.43x | $-7.68 Million | $-7.86 Million | $18.06 Million | ▼ -17.0% |
| 2019 | -0.36x | $-2.60 Million | $-2.78 Million | $7.16 Million | — |